| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/24/2011 | US20110045069 Precursor compounds of sweet taste receptor antagonists for the prevention or treatment of disease |
| 02/24/2011 | US20110045068 Pharmaceutical formulations for the oral administration of ppi |
| 02/24/2011 | US20110045067 Soft gel capsules |
| 02/24/2011 | US20110045066 Pharmaceutical compound containing silymarin and carbopol, its manufacturing process and its use as a regenerator of the pancreatic tissue and cells of endogenous secretion damaged by diabetes mellitus |
| 02/24/2011 | US20110045065 Substance having antioxidant, geroprotective and anti-ischemic activity and method for the preparation thereof |
| 02/24/2011 | US20110045064 Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione |
| 02/24/2011 | US20110045063 Phosphate-binding magnesium salts and uses thereof |
| 02/24/2011 | US20110045062 Formulation |
| 02/24/2011 | US20110045061 Gene therapy for diabetic ischemic disease |
| 02/24/2011 | US20110045060 Kit for detecting cancer cells metastasizing into sentinel lymph node |
| 02/24/2011 | US20110045059 Vaccine against varicella zoster virus |
| 02/24/2011 | US20110045058 Transfection reagent |
| 02/24/2011 | US20110045057 Virosomes Comprising Hemagglutinin Derived from an Influenza Virus Produced in a Cell Line, Compositions, Methods of Manufacturing, Use Thereof |
| 02/24/2011 | US20110045054 Materials and methods for treating and managing plaque disease |
| 02/24/2011 | US20110045053 Isolated population of luminal stem cells that give rise to prostate cancer and methods of using same |
| 02/24/2011 | US20110045052 Bioactive Glass Coatings |
| 02/24/2011 | US20110045049 Immunomodulating compositions and methods of use |
| 02/24/2011 | US20110045048 Bone graft and scaffolding materials immobilized with type i collagen binding peptides |
| 02/24/2011 | US20110045047 Hemostatic implant |
| 02/24/2011 | US20110045046 Glycopeptides and methods of making and using them |
| 02/24/2011 | US20110045045 Production of and uses for decellularized lung tissue |
| 02/24/2011 | US20110045041 Compositions and methods for the delivery of agents |
| 02/24/2011 | US20110045037 Foam containing benzoyl peroxide |
| 02/24/2011 | US20110045035 Methods of treating ophthalmic disorders |
| 02/24/2011 | US20110045034 Gelatin Sponge Comprising an Active Ingredient, Its Preparation and Use |
| 02/24/2011 | US20110045033 Combination of Itriglumide and Proton Pump Inhibitors in the Treatment of Gastrointestinal and Related Disorders |
| 02/24/2011 | US20110045032 Composition, formulations & kit for treatment of respiratory and lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s) |
| 02/24/2011 | US20110045031 Use of Buckysome or Carbon Nanotube for Drug Delivery |
| 02/24/2011 | US20110045030 Crosslinkable polyisobutylene-based polymers and medical devices containing the same |
| 02/24/2011 | US20110045029 Oral formulation for delivery of poorly absorbed drugs |
| 02/24/2011 | US20110045028 Sustained release preparation |
| 02/24/2011 | US20110045017 Hiv vaccine for mucosal delivery |
| 02/24/2011 | US20110044915 Confectionery containing algae for the prevention of oro-dental infections |
| 02/24/2011 | US20110044913 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone hemi-fumarate |
| 02/24/2011 | US20110044900 Method for treating and/or diagnosing tumor by gold particles coated with a polymer |
| 02/24/2011 | US20110044893 Vascular targets for detecting, imaging and treating neoplasia or neovasculature |
| 02/24/2011 | DE102009024949B3 Anordnung zur ferngesteuerten Wirkstoff-Freisetzung Arrangement for remote-controlled drug release |
| 02/24/2011 | DE102005062440B4 Proteinbasiertes Trägersystem zur Resistenzüberwindung von Tumorzellen Protein-based carrier system to overcome resistance of tumor cells |
| 02/24/2011 | CA2772231A1 Chocolate delivery system for pharmaceuticals and nutraceuticals |
| 02/24/2011 | CA2771358A1 Drug delivery systems (wafer) for pediatric use |
| 02/24/2011 | CA2771308A1 Topical gels |
| 02/24/2011 | CA2771207A1 Tablet manufacture |
| 02/24/2011 | CA2770609A1 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
| 02/24/2011 | CA2770341A1 Riboflavin based aerosol and use as placebo in trials |
| 02/24/2011 | CA2746459A1 Use of pharmaceutical compositions in preparing pharmaceuticals for treating diabetic ulcer |
| 02/23/2011 | EP2287589A1 Skin-substitutive membrane, metal mold, and method of evaluating agent for external application onto skin |
| 02/23/2011 | EP2287290A2 Nestin-expressing hair follicle stem cells |
| 02/23/2011 | EP2287230A1 Docetaxel polymer derivative, method for producing same and use of same |
| 02/23/2011 | EP2286860A1 Medical powder cartridge and inhaler fitted with same |
| 02/23/2011 | EP2286847A1 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 02/23/2011 | EP2286834A2 Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response |
| 02/23/2011 | EP2286831A1 A method of inducing a CTL response |
| 02/23/2011 | EP2286819A1 Pharmceuttical composition for treating cardio-cerebro vascular diseases and preparative method and kit thereof |
| 02/23/2011 | EP2286818A1 Fulvestrant formulation |
| 02/23/2011 | EP2286815A2 Methylphenidate Modified Release Formulations |
| 02/23/2011 | EP2286814A1 Transdermal preparation containing palonosetron |
| 02/23/2011 | EP2286806A1 Solid formulations of ospemifene |
| 02/23/2011 | EP2286804A1 A method of treating degenerative disc disease |
| 02/23/2011 | EP2286802A1 Transdermal therapeutic system |
| 02/23/2011 | EP2286801A2 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 02/23/2011 | EP2286800A1 Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs |
| 02/23/2011 | EP2286799A2 Microspheres for active embolization |
| 02/23/2011 | EP2286798A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 02/23/2011 | EP2286797A2 Dry powder composition comprising co-jet milled particles for pulmonary inhalation |
| 02/23/2011 | EP2286796A2 Controlled release formulation comprising albuterol |
| 02/23/2011 | EP2286795A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 02/23/2011 | EP2286794A1 Use of cationic liposomes comprising an active drug |
| 02/23/2011 | EP2286793A2 Pharmaceutical formulations comprising cannabidiol |
| 02/23/2011 | EP2286792A1 Microemulsions with an adsorbent surface, comprising a microdroplet emulsion |
| 02/23/2011 | EP2286791A1 Polymeric implants, preferably containing a mixture of PEG and PLG, for controlled release of active agents, preferably a GnRH |
| 02/23/2011 | EP2286676A1 Method for treatment of chronic venous insufficiencies using an extract of red vine leaves |
| 02/23/2011 | EP2286666A1 Versatile disinfectant |
| 02/23/2011 | EP2285853A2 Micellic assemblies |
| 02/23/2011 | EP2285421A2 Methods for production and use of substance-loaded erythrocytes (s-les) for observation and treatment of microvascular hemodynamics |
| 02/23/2011 | EP2285418A1 Stimuli-responsive hydrogel |
| 02/23/2011 | EP2285414A1 Fully synthetic albumin analogue |
| 02/23/2011 | EP2285412A1 Formulations of peg-functionalised serine proteases with high concentrations of an aromatic preservative |
| 02/23/2011 | EP2285392A2 Anticancer methods employing extracts of gleditsia sinensis lam |
| 02/23/2011 | EP2285364A2 Therapeutic replenishment and enrichment of ocular surface lubrication |
| 02/23/2011 | EP2285363A2 Alpha adrenergic receptor agonists for treatment of inflammatory diseases |
| 02/23/2011 | EP2285362A1 Composition for transdermal delivery of cationic active agents |
| 02/23/2011 | EP2285361A2 Therapeutic calcium phosphate particles and methods of making and using same |
| 02/23/2011 | EP2285360A2 Medicament delivery device having an electronic circuit system |
| 02/23/2011 | EP2285359A2 Solid pharmaceutical formulation with delayed release |
| 02/23/2011 | EP2285358A1 Pulsatile release of valsartan |
| 02/23/2011 | EP2285357A1 Pharmaceutical compositions comprising brivaracetam |
| 02/23/2011 | EP2285356A2 Process for preparing a tablet comprising metformin |
| 02/23/2011 | EP2285355A2 Process for preparing a high drug load tablet |
| 02/23/2011 | EP2285354A2 Process for preparing a low drug load tablet |
| 02/23/2011 | EP2285353A1 Modified release formulations of hmg coa reductase inhibitors |
| 02/23/2011 | EP2285352A2 Atorvastatin compositions |
| 02/23/2011 | EP2285351A2 Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas |
| 02/23/2011 | EP2285350A2 Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles |
| 02/23/2011 | EP2285349A1 Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer |
| 02/23/2011 | EP2285348A1 Opioid composition for treating skin lesions |
| 02/23/2011 | EP2285347A2 Compositions and methods for treating digestive disorders |
| 02/23/2011 | EP2285346A1 Methods for improving lid margin and tear film function and treatment of lid margin desease using tetracycline family antibiotics |
| 02/23/2011 | EP2285345A1 Pulmonary delivery of a fluoroquinolone |
| 02/23/2011 | EP2285328A2 Hemorrhoid treatment device |
| 02/23/2011 | EP2285324A1 Plaster with medication dispenser |